Find support for everystep of your treatment, including how to access TAVALISSE, copay assistance, patient support services, and additional resources
RIGEL ONECARE is here to support you along your treatment journey with TAVALISSE*
Nurse Navigation
Reimbursement Specialists
Financial and Copay Assistance
Nurses at RIGEL ONECARE are fully trained to support you and will:
- Connect with your insurance plan and your healthcare providers to understand your coverage
- Determine if you qualify and help you enroll in copay and financial assistance programs
- Answer any questions you may have during your treatment with TAVALISSE
- Be ready and available Monday-Friday 8 AM to 8 PM ET to address any questions or concerns
Enroll today!
Start here to see how RIGEL ONECARE can support you
All RIGEL ONECARE programs are subject to eligibility requirements and changes. Criteria above do not represent all criteria for each program.
Must be U.S. resident or U.S. territory resident. Restrictions apply.
TAVALISSE financial assistance
Eligible patients with commercial insurance pay as little as $15 per prescription fill with the TAVALISSE copay assistance program.†
- Fill out and submit your information to determine if you are eligible
- Print out the copay card and have it available when speaking with the specialty pharmacy
All RIGEL ONECARE programs are subject to eligibility requirements and changes. Criteria above do not represent all criteria for each program. Must be U.S. resident or U.S. territory resident. Restrictions apply.
Additional TAVALISSE resources
Visit TAVALISSE.com for additional resources to help guide and support you or the person you care for during treatment with TAVALISSE
Platelet Disorder Support Association
PDSA helps make the lives of people with ITP better by providing patients with education, advocacy, research, and support services
Foundations with financial assistance
The following groups may be able to give you additional help with paying for your ITP treatment
IMPORTANT SAFETY INFORMATION
What is TAVALISSE
TAVALISSE is a prescription medication used to treat adults with low platelet counts due to chronic immune thrombocytopenia (ITP) when a prior treatment for ITP has not worked well enough. It is not known if TAVALISSE is safe and effective in children.
What is the most important information I should know about TAVALISSE?
TAVALISSE can cause serious side effects including:
- High blood pressure (hypertension). New or worsening high blood pressure is common in people treated with TAVALISSE and can be severe. Your healthcare provider will check your blood pressure regularly during treatment with TAVALISSE. If needed, your healthcare provider may start you on blood pressure medicine or change your current medicine to treat your blood pressure. Tell your healthcare provider if you get headaches, confusion, dizziness, chest pain, or shortness of breath.
- Liver problems. Changes in liver function blood tests are common with TAVALISSE. Liver problems may occur and can be severe. Your healthcare provider will regularly do blood tests to check how well your liver is working during treatment with TAVALISSE.
- Diarrhea. Diarrhea is common in people treated with TAVALISSE and can be severe. Tell your healthcare provider if you get diarrhea during treatment with TAVALISSE. Your healthcare provider may recommend changes in your diet, drinking more water, or medicine to limit these symptoms.
- Decreases in white blood cell count (neutropenia). Decreases in your white blood cell count are common with TAVALISSE and can be severe. This may increase your risk for infection, including serious infections. Your healthcare provider will regularly do blood tests to check your white blood cell counts.
Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with TAVALISSE if you have side effects.
Before you take TAVALISSE, tell your healthcare provider about all of your medical conditions, including if you:
- have high blood pressure
- have liver problems
- are pregnant or plan to become pregnant. TAVALISSE can harm your unborn baby.
- Your healthcare provider will check if you are pregnant before starting treatment with TAVALISSE.
- Females who can become pregnant should use effective birth control during treatment with TAVALISSE and for at least 1 month after the last dose.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking TAVALISSE with certain other medicines may affect how the other medicines work or how TAVALISSE works.
What are the possible side effects of TAVALISSE?
The most common side effects of TAVALISSE include:
- Nausea, rash, dizziness, tiredness, respiratory infection, chest pain, and stomach (abdomen) pain.
These are not all the side effects of TAVALISSE. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA, at 1‑800‑FDA‑1088.
BACK TO TOP
Product questions or medical inquiries?
Please send any medical inquiries and report complaints or adverse events to: Rigel Medical Communications Center at 1‑800-983-1329 or producthelp@rigel.com
You may also report report adverse events associated with taking our prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088 (1-800-332-1088).
Call 1-833-RigelOC (1-833-744-3562) Monday-Friday 8 AM to 8 PM ET to contact RIGEL ONECARE